Clinical Trial: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435779) titled 'Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study' on Feb. 11.

Brief Summary: A Single-Center, Open-Label, Single-Arm Exploratory Clinical Study on the Use of Autologous CAR-T Cell Therapy Injection for the Treatment of Refractory and Relapsing Ulcerative Colitis: A Preliminary Exploration of 12-Week Clinical Remission with Autologous CAR-T Cell Injection in Refractory and Relapsing Ulcerative Colitis.

Study Start Date: Feb. 04

Study Type: INTERVENTIONAL

Condition: UC

Intervention: DRUG: BCMA CAR-T or CD19 CAR-T or CD19xBCMA

Autologous BCMA/CD19/CD19xBCMA-targetin...